{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-271578","form_type":"8-K","ticker":"JANX","cik":"0001817713","company_name":"Janux Therapeutics, Inc.","filed_at":"2024-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.800861+00:00","generated_at":"2026-05-29T07:21:52.975448+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Janux Therapeutics prices $350M public offering of common stock and pre-funded warrants","bullets":["Priced 5,317,460 shares at $63.00/share and pre-funded warrants for 238,095 shares at $62.999","Gross proceeds expected ~$350M before expenses; funds to advance clinical pipeline and for general purposes","Underwriters granted 30-day option to purchase up to additional 833,333 shares","Offering expected to close Dec 6, 2024; joint book-runners: BofA, TD Cowen, Stifel, Cantor, William Blair"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-271578","json":"https://secwatch.observer/filing/0001193125-24-271578.json","markdown":"https://secwatch.observer/filing/0001193125-24-271578.md","text":"https://secwatch.observer/filing/0001193125-24-271578.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817713/000119312524271578/0001193125-24-271578-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817713/000119312524271578/d877731d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T07:21:52.975448+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}